AIDX
20/20 Biolabs, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$0.59
−3.27%Leverage
- Debt / equity
- 0.18x
- Net debt / equity
- -1.26x
- Debt / assets
- 0.09x
- Debt / EBITDA
- -0.12x
- Net debt / EBITDA
- 0.83x
Liquidity & coverage
- Current ratio
- 1.99x
- Quick ratio
- 1.95x
- Cash ratio
- 1.78x
- Interest coverage
- -6.34x
- EBITDA / interest
- -6.91x
- Working capital
- $2.5M
Cash & dividend
- FCF / debt
- -4.87x
- Cash flow / debt
- -4.88x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026